Significantly, an absolute increase of 5% or more in tumor PD-L1 expression induced by treatment tended to improve progression-free survival (PFS) in OC (7.4 months vs. 3.5 months, p=0.07), whereas baseline pretreatment PD-L1 expression was not associated with ORR (10). The gene discussed is CD274; the disease is neoplasm.